Patients (gender) | Genetic diagnosis | GH status | Chronological age at GH start | Bone age at GH start | Pubertal staging | GH dose mg/kgnwk | Height SDS change | |
---|---|---|---|---|---|---|---|---|
Naselli et al. 1998 [11] | Patient 1 (F) | Not reported | Deficient, based on GH stim test and IGF1 level, no data | 11.1 y | 8–9 y | Prepubertal | 0.23 | None |
Patient 2 (F) | Not reported | Deficient, based on GH stim test and IGF1 level, no data | 11.1 y | 8–9 y | Prepubertal | 0.23 | None | |
Stagi et al. 2008 [13] | Patient 3 (M) | Not reported | Partial deficiency, Peak after arginine 6.8, after insulin 12.7, low nocturnal GH 2.7 | 12 y | 9 y 6 m | G2, PH2, T4 ml bilaterally | 0.26 | + 0.7 SDS over 5 years |
Patient 4 (M) | c2722C > T (p.R908X) | Partial deficiency. Peak after Clonidine 10.2, peak after insulin5.4, low nocturnal GH 2.38 | 9 y 9 m | 7 y8 m | Prepubertal | 0.26 | + 1.9 SDS over 7 years | |
Sarafoglou et al. 2010 [14] | Patient 5 (M) | Not reported | No deficiency. Low IGF1 and normal IGFBP3 | 7 y | ~3 y delay | Prepubertal | 0.3–0.43 | +1.81 SDS over 3 years |
Patient 6 (F) | Not reported | No deficiency. Low IGF1 and normal IGFBP3 | 6.95 y | ~ 6 m delay | Prepubertal | 0.34–0.54 | +1.95 SDS over 2 years | |
Sohn et al. 2012 [12] | Patient 7 (F) | c2520dupT (p.Arg841LysfsX3) | Deficient (peak after insulin 3.17 and after L-dopa 5) | 4 y | 2.6 y | Prepubertal | 0.2 | + 0.4 SD over 10 years |
Patient 8 (M) | c1630C > T (p.Arg544X) | Not deficient (peak after glucagon 9.86, after L-dopa 9.7) | 14 y | 16 y | Pubertal | Not reported | None (1 cm over 6 months) |